top of page
Governance
The PIONeeR Project RHU is led by a consortium bridging together Aix-Marseille Université (AMU), Inserm, CNRS, the "Assistance Publique Hôpitaux de Marseille" (AP-HM), Gustave Roussy, Centre Léon-Bérard de Lyon (CLB), ImCheck Therapeutics, Innate Pharma, Veracyte and AstraZeneca.
Discover the members of the Independent Scientific Advisory Board (SAB)
Focus
KEY FIGURES: 2555 days, 3 countries, more than 100 scientists, 8 research labs, 17 hospitals, 225,510,000€ including 8,502,000€ of NRA funding
RHU COORDINATOR : Aix-Marseille Université
CLINICAL TRIAL SPONSOR : Assistance Publique Hôpitaux de Marseille
PROJECT INITIATOR : Marseille Immunopole
DIRECTION : Professeur Fabrice BARLESI (Université Paris-Saclay, Institut Gustave Roussy)
They are involved in the PIONeeR project
bottom of page